Print | Need Larger Text? | Share

Maximum Residue Limits (MRLs)

• Consultation - Maximum residue limit (MRL) proposal for Amoxicillin, Neomycin, Ormetoprim, Tetracycline, Chlortetracycline, Oxytetracycline, Tilmicosin, Tricaine Methanesulfonate, Tulathromycin and Zoalene
• Consultation - Maximum residue limit (MRL) proposal for Albendazole, Fenbendazole, Flunixin, Zilpaterol, Doramectin, Emamectin, Ivermectin, Moxidectin, Streptomycin, Dihydrostreptomycin and Gentamicin sulphate [2009-12-16]
• Proposal for Amoxicillin [2007-04-05]
• Proposal for Trenbolone Acetate [2006-04-18]
• Proposal for Tulathromycin [2007-04-05]
• Proposal for Zeranol [2006-04-18]
• Proposal for Neomycin [2007-01-02]
• Proposal for Altrenogest [2005-06-18]
• Proposal for Ractopamine [2005-08-01]
• Proposal for Ketoprofen [2005-01-24]
• Proposal for Danofloxacin [2005-01-24]
• Proposal for Florfenicol [2005-01-24]
• Proposal for Melengestrol Acetate (MGA) [2005-01-24]
• Proposal for Diclazuril [2004-04-16]
• Proposal for Eprinomectin [2004-03-29]
• Proposal for Enrofloxacin [2004-02-18]
• Proposal for Monensin [2004-01-15]
• Proposal for Doramectin [2003-12-05]
• Proposal for Ketoprofen [2003-12-05]
• Proposal for Narasin [2003-12-05]
• Proposal for Ceftiofur [2003-01-08]
• Proposal for Flunixin [2003-05-13]
• Proposal for Lincomycin [2003-06-23]
• Proposal for Oxytetracycline [2003-05-13]
• Proposal for Pirlimycin [2002-12-20]